United States - English - NLM (National Library of Medicine)

sandoz inc. - clindamycin phosphate (unii: eh6d7113i8) (clindamycin - unii:3u02el437c) - clindamycin 10 mg in 1 g - clindamycin and benzoyl peroxide gel, 1%/5% is indicated for the topical treatment of acne vulgaris. clindamycin and benzoyl peroxide gel, 1%/5% is contraindicated in those individuals who have shown hypersensitivity to any of its components or to lincomycin. it is also contraindicated in those having a history of regional enteritis, ulcerative colitis, or antibiotic-associated colitis.

United States - English - NLM (National Library of Medicine)

bausch health us llc - clindamycin phosphate (unii: eh6d7113i8) (clindamycin - unii:3u02el437c), benzoyl peroxide (unii: w9wzn9a0gm) (benzoyl peroxide - unii:w9wzn9a0gm) - clindamycin 10 mg in 1 g - benzaclin topical gel is indicated for the topical treatment of acne vulgaris. benzaclin topical gel is contraindicated in those individuals who have shown hypersensitivity to any of its components or to lincomycin. it is also contraindicated in those having a history of regional enteritis, ulcerative colitis, or antibiotic-associated colitis.

United States - English - NLM (National Library of Medicine)

lg household and healthcare, inc. - bemotrizinol (unii: pwz1720cbh) (bemotrizinol - unii:pwz1720cbh), octinoxate (unii: 4y5p7mud51) (octinoxate - unii:4y5p7mud51), titanium dioxide (unii: 15fix9v2jp) (titanium dioxide - unii:15fix9v2jp), amiloxate (unii: 376ktp06k8) (amiloxate - unii:376ktp06k8), diethylamino hydroxybenzoyl hexyl benzoate (unii: anq870jd20) (diethylamino hydroxybenzoyl hexyl benzoate - unii:anq870jd20) - bemotrizinol 1 ml in 100 ml - stop use if a rash or irritation develops and lasts.

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

a a h pharmaceuticals ltd - benzoyl peroxide - cutaneous gel - 50mg/1gram

United States - English - NLM (National Library of Medicine)

prugen, inc. - benzoyl peroxide (unii: w9wzn9a0gm) (benzoyl peroxide - unii:w9wzn9a0gm) - benzoyl peroxide 60 mg - benzepro® foaming cloths are indicated for use in the topical treatment of mild to moderate acne vulgaris. benzepro® foaming cloths should not be used in patients who have shown hypersensitivity to benzoyl peroxide or to any of the other ingredients in the product. discontinue use if hypersensitivity is observed.

Australia - English - Department of Health (Therapeutic Goods Administration)

glaxosmithkline australia pty ltd - benzoyl peroxide, quantity: 50 mg/g; clindamycin phosphate, quantity: 11.9 mg/g (equivalent: clindamycin, qty 10 mg/g) - gel - excipient ingredients: silicon dioxide; purified water; glycerol; sodium hydroxide; disodium lauril sulfosuccinate; dimeticone 100; carbomer 980; poloxamer; disodium edetate - for the topical treatment of comedo, papules and pustular acne vulgaris.

Israel - English - Ministry of Health

perrigo israel agencies ltd - benzoyl peroxide; erythromycin - gel - benzoyl peroxide 87.125 mg/g; erythromycin 0.8 g - benzoyl peroxide, combinations - benzoyl peroxide, combinations - for topical treatment of acne vulgaris.

United States - English - NLM (National Library of Medicine)

walgreens - benzoyl peroxide (unii: w9wzn9a0gm) (benzoyl peroxide - unii:w9wzn9a0gm) - benzoyl peroxide 2.5 g in 100 ml - benzoyl peroxide - 2.50%         acne treatment • treats and helps prevent acne blemishes. benzoyl peroxide - 2.50%               acne treatment • treats and helps prevent acne blemishes. do not use if you have very sensitive skin or if you are sensitive to benzoyl peroxide. • skin irritation and dryness is more likely to occur if you use another topical acne medication at the same time. if irritation occurs, only use one topical acne medication at a time. • rinse right away with water if it gets in eyes • avoid unnecessary sun exposure and use a sunscreen •avoid contact with eyes, lips, and mouth • avoid contact with hair and dyed fabrics, which may be bleached by this product • skin irritation may occurs, characterized by redness, burning, itching, peeling, or possibly swelling. irritation may be reduced by using the product less frequently or in a lower concentration. stop use and ask a doctor if irritation becomes severe. if product is swallowed, get medical help or contact a poison control center right

Canada - English - Health Canada

jan marini skin research inc - benzoyl peroxide - lotion - 5.0% - benzoyl peroxide 5.0% - keratolytic agents

Canada - English - Health Canada

jan marini skin research inc - benzoyl peroxide - solution - 2.5% - benzoyl peroxide 2.5% - keratolytic agents